Warning Letter — gethyppe.com
The FDA Center for Tobacco Products (CTP) issued a Warning Letter to gethyppe.com on May 19, 2026, regarding the marketing and sale of unauthorized tobacco products.
The action specifically affects gethyppe.com and has implications for online retailers, distributors, and manufacturers of electronic nicotine delivery systems (ENDS).
This enforcement action indicates ongoing FDA surveillance of the e-commerce landscape for ENDS. It suggests that the agency continues to prioritize the removal of nicotine products from the market that lack valid marketing authorization. For regulatory professionals, this reinforces the risk of operating without explicitly confirmed PMTA (Premarket Tobacco Product Application) status.
E-commerce firms in the nicotine space must verify that all marketed products have received necessary pre-market authorizations. Regulatory teams should conduct an immediate audit of online inventory to ensure and document current authorization status for every SKU listed.
FDA Warning Letter issued to: gethyppe.com. 05/19/2026 — Center for Tobacco Products. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/gethyppecom-730121-05192026
Open in openFDA / FDA.gov